Next-gen immunotherapy: a guide for CGT developers

Innovative cellular immunotherapies are transforming cancer treatment, but challenges remain in analytics, process development, manufacturing, and scaling. In this discussion, Charles River Laboratories’ Alex Sargent (Director of Process Development) shares strategies to streamline cell therapy development, accelerate the path to IND, and optimize workflows for regulatory approval.



Please enter your email to access content Read now